These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 37684641)
21. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway. Huang J; Yang J; Zhang Y; Lu D; Dai Y Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332 [TBL] [Abstract][Full Text] [Related]
22. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway. Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620 [TBL] [Abstract][Full Text] [Related]
23. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
24. ChIP-seq and RNA-seq Reveal the Involvement of Histone Lactylation Modification in Gestational Diabetes Mellitus. Huang X; Yip K; Nie H; Chen R; Wang X; Wang Y; Lin W; Li R J Proteome Res; 2024 Jun; 23(6):1937-1947. PubMed ID: 38776154 [TBL] [Abstract][Full Text] [Related]
25. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma. Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027 [TBL] [Abstract][Full Text] [Related]
26. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Li J; Chen Z; Jin M; Gu X; Wang Y; Huang G; Zhao W; Lu C Cell Signal; 2024 Dec; 124():111468. PubMed ID: 39395526 [TBL] [Abstract][Full Text] [Related]
27. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development. Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881 [No Abstract] [Full Text] [Related]
28. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy. Zhou J; Ma X; Liu X; Liu Y; Fu J; Qi Y; Liu H Genes Genomics; 2024 Sep; 46(9):991-1011. PubMed ID: 39127851 [TBL] [Abstract][Full Text] [Related]
29. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers. Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856 [TBL] [Abstract][Full Text] [Related]
30. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP. Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353 [TBL] [Abstract][Full Text] [Related]
31. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway. Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332 [TBL] [Abstract][Full Text] [Related]
32. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway. Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425 [TBL] [Abstract][Full Text] [Related]
33. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
34. GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway. Zhou J; Xu W; Wu Y; Wang M; Zhang N; Wang L; Feng Y; Zhang T; Wang L; Mao A Oncogene; 2023 Nov; 42(45):3319-3330. PubMed ID: 37749229 [TBL] [Abstract][Full Text] [Related]
35. Metabolic regulation of gene expression by histone lactylation. Zhang D; Tang Z; Huang H; Zhou G; Cui C; Weng Y; Liu W; Kim S; Lee S; Perez-Neut M; Ding J; Czyz D; Hu R; Ye Z; He M; Zheng YG; Shuman HA; Dai L; Ren B; Roeder RG; Becker L; Zhao Y Nature; 2019 Oct; 574(7779):575-580. PubMed ID: 31645732 [TBL] [Abstract][Full Text] [Related]
36. Lactate, histone lactylation and cancer hallmarks. Lv X; Lv Y; Dai X Expert Rev Mol Med; 2023 Jan; 25():e7. PubMed ID: 36621008 [TBL] [Abstract][Full Text] [Related]
37. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways. Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479 [TBL] [Abstract][Full Text] [Related]
38. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246 [TBL] [Abstract][Full Text] [Related]
39. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Han Y; Tang Z; Zhao Y; Li Q; Wang E Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138 [TBL] [Abstract][Full Text] [Related]
40. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]